Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jochen Utikal

Showing results (121-130 of 276) with videos related to

Pageof 28
Sort By:
Frontiers in Immunology|March 2, 2023
Immunosuppressive capacity of circulating MDSC predicts response to immune checkpoint inhibitors in melanoma patientsVera Petrova, Christopher Groth, Rebekka Bitsch, et al.
Plos One|February 22, 2014
Desmoglein 2 depletion leads to increased migration and upregulation of the chemoattractant secretoneurin in melanoma cellsWiebke K Peitsch, Yvette Doerflinger, Reiner Fischer-Colbrie, et al.
International Journal of Molecular Sciences|June 27, 2024
Generation of Myeloid-Derived Suppressor Cells Mediated by MicroRNA-125a-5p in MelanomaSamantha Lasser, Feyza Gul Ozbay Kurt, Lennart Fritz, et al.
Frontiers in Immunology|April 1, 2021
Harnessing Mesenchymal Stromal Cells for the Engineering of Human Hematopoietic NichesAlice Pievani, Roberto Savoldelli, Juliane Poelchen, et al.
BMC Medical Genomics|March 2, 2016
SOX5 is involved in balanced MITF regulation in human melanoma cellsTheresa Kordaß, Claudia E M Weber, Marcus Oswald, et al.
Oncotarget|May 17, 2018
<i>MYC</i> gene amplification is a rare event in atypical fibroxanthoma and pleomorphic dermal sarcomaTimo Gaiser, Daniela Hirsch, Azadeh Orouji, et al.
Clinical Chemistry|February 28, 2018
Liquid Profiling of Circulating Tumor DNA in Plasma of Melanoma Patients for Companion Diagnostics and Monitoring of BRAF Inhibitor TherapyVerena Haselmann, Christoffer Gebhardt, Ingrid Brechtel, et al.
Nature|August 12, 2009
Immortalization eliminates a roadblock during cellular reprogramming into iPS cellsJochen Utikal, Jose M Polo, Matthias Stadtfeld, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 15, 2016
T-Cell Therapy Enabling Adenoviruses Coding for IL2 and TNFα Induce Systemic Immunomodulation in Mice With Spontaneous MelanomaSiri Tähtinen, Carolin Blattner, Markus Vähä-Koskela, et al.
Cancer Immunology, Immunotherapy : CII|May 26, 2018
T-lymphocyte profiles differ between keratoacanthomas and invasive squamous cell carcinomas of the human skinCorinne Bauer, Ashik Ahmed Abdul Pari, Viktor Umansky, et al.
Pageof 28

Showing results (121-130 of 276) with videos related to

Sort By:
Pageof 28
Frontiers in Immunology|March 2, 2023
Immunosuppressive capacity of circulating MDSC predicts response to immune checkpoint inhibitors in melanoma patientsVera Petrova, Christopher Groth, Rebekka Bitsch, et al.
Plos One|February 22, 2014
Desmoglein 2 depletion leads to increased migration and upregulation of the chemoattractant secretoneurin in melanoma cellsWiebke K Peitsch, Yvette Doerflinger, Reiner Fischer-Colbrie, et al.
International Journal of Molecular Sciences|June 27, 2024
Generation of Myeloid-Derived Suppressor Cells Mediated by MicroRNA-125a-5p in MelanomaSamantha Lasser, Feyza Gul Ozbay Kurt, Lennart Fritz, et al.
Frontiers in Immunology|April 1, 2021
Harnessing Mesenchymal Stromal Cells for the Engineering of Human Hematopoietic NichesAlice Pievani, Roberto Savoldelli, Juliane Poelchen, et al.
BMC Medical Genomics|March 2, 2016
SOX5 is involved in balanced MITF regulation in human melanoma cellsTheresa Kordaß, Claudia E M Weber, Marcus Oswald, et al.
Oncotarget|May 17, 2018
<i>MYC</i> gene amplification is a rare event in atypical fibroxanthoma and pleomorphic dermal sarcomaTimo Gaiser, Daniela Hirsch, Azadeh Orouji, et al.
Clinical Chemistry|February 28, 2018
Liquid Profiling of Circulating Tumor DNA in Plasma of Melanoma Patients for Companion Diagnostics and Monitoring of BRAF Inhibitor TherapyVerena Haselmann, Christoffer Gebhardt, Ingrid Brechtel, et al.
Nature|August 12, 2009
Immortalization eliminates a roadblock during cellular reprogramming into iPS cellsJochen Utikal, Jose M Polo, Matthias Stadtfeld, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 15, 2016
T-Cell Therapy Enabling Adenoviruses Coding for IL2 and TNFα Induce Systemic Immunomodulation in Mice With Spontaneous MelanomaSiri Tähtinen, Carolin Blattner, Markus Vähä-Koskela, et al.
Cancer Immunology, Immunotherapy : CII|May 26, 2018
T-lymphocyte profiles differ between keratoacanthomas and invasive squamous cell carcinomas of the human skinCorinne Bauer, Ashik Ahmed Abdul Pari, Viktor Umansky, et al.
Pageof 28